Bioharvest Sciences Inc Asset Turnover Ratio (BHST), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Bioharvest Sciences Inc   (BHST)
 

Bioharvest Sciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Bioharvest Sciences Inc asset turnover ratio, the ability of Bioharvest Sciences Inc 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.67 in the fourth quarter (Dec 31 2025), BHST's balance sheet remain strong.

Within sector Bioharvest Sciences Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition



BHST Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Asset Change 545.25 % 343.48 % - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.67 - - - -
BHST's Total Ranking # # # # #
Seq. Asset Change 35.41 % 0 % 0 % 376.51 % -6.93 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Nephros Inc   1.46 $ 18.625  Millions$ 12.727  Millions
Aspira Women s Health inc   1.46 $ 8.915  Millions$ 6.101  Millions
Viemed Healthcare Inc   1.44 $ 275.332  Millions$ 191.049  Millions
Infusystem Holdings Inc  1.42 $ 143.436  Millions$ 101.143  Millions
Medpace Holdings Inc   1.41 $ 2,530.234  Millions$ 1,799.382  Millions
Aesthetic Medical International Holdings Group Limited  1.41 $ 106.636  Millions$ 75.867  Millions
Mimedx Group Inc   1.36 $ 416.672  Millions$ 305.793  Millions
Aveanna Healthcare Holdings Inc   1.34 $ 2,433.199  Millions$ 1,813.637  Millions
Evolus Inc   1.34 $ 297.107  Millions$ 221.757  Millions
Karyopharm Therapeutics Inc   1.34 $ 146.067  Millions$ 109.310  Millions
Longduoduo Co Ltd  1.34 $ 2.722  Millions$ 2.038  Millions
Xtant Medical Holdings Inc   1.33 $ 133.273  Millions$ 99.945  Millions
Vaxart Inc   1.32 $ 237.258  Millions$ 179.428  Millions
Evofem Biosciences Inc   1.32 $ 20.183  Millions$ 15.335  Millions
Elite Pharmaceuticals Inc   1.32 $ 138.547  Millions$ 105.341  Millions
Hims and Hers Health Inc   1.31 $ 2,347.378  Millions$ 1,789.326  Millions
Idexx Laboratories Inc  1.30 $ 4,303.579  Millions$ 3,320.489  Millions
Sanuwave Health Inc   1.29 $ 44.051  Millions$ 34.211  Millions
Electromed Inc   1.27 $ 68.064  Millions$ 53.417  Millions
Sonoma Pharmaceuticals Inc   1.27 $ 17.722  Millions$ 13.942  Millions
Rosecliff Acquisition Corp I  1.27 $ 20.547  Millions$ 16.202  Millions
Apollomics Inc   1.27 $ 8.500  Millions$ 6.714  Millions
Hca Healthcare Inc   1.26 $ 75,600.000  Millions$ 59,950.250  Millions
Trisalus Life Sciences Inc   1.25 $ 44.186  Millions$ 35.434  Millions
Rockwell Medical inc   1.24 $ 68.695  Millions$ 55.304  Millions
Ardent Health Inc   1.24 $ 6,324.339  Millions$ 5,095.773  Millions
Warby Parker Inc   1.24 $ 871.579  Millions$ 703.124  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.23 $ 17.703  Millions$ 14.410  Millions
Precipio inc   1.22 $ 24.049  Millions$ 19.768  Millions
Tactile Systems Technology Inc   1.21 $ 329.146  Millions$ 271.602  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.